Salomon & Ludwin’s Nuvalent NUVL Stock Holding History

Salomon & Ludwin’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.49K	Hold	71	–	–	﹤0.01%	1633
2025 Q4	$6.95K	Hold	71	–	–	﹤0.01%	1640
2025 Q3	$5.98K	Buy	+71	New	+$5.61K	﹤0.01%	1635

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Salomon & Ludwin's NUVL Position: Q1 2026 in Review

Salomon & Ludwin held its Nuvalent (NUVL) position steady in Q1 2026 at 71 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Salomon & Ludwin first reported a position in NUVL in Q3 2025 and has held it in 3 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Salomon & Ludwin held 71 shares of Nuvalent worth $7.49K as of Q1 2026.
Salomon & Ludwin left its Nuvalent share count unchanged in Q1 2026.
Nuvalent made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1633 holding.
Salomon & Ludwin first reported a position in Nuvalent in Q3 2025 and has held it in 3 quarters since.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.